Sanofi

Insider Reports History

Location
Paris, France
Signature
/s/ Alexandra Roger, Alexandra Roger, Head of Legal Corporate & Finance
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sanofi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Translate Bio, Inc. 10%+ Owner Common Stock, par value $0.001 per share 75.7M $2.88B $38.00 14 Sep 2021 Direct
MeiraGTx Holdings plc 10%+ Owner Ordinary Shares ($0.00003881 par value per share) 11.5M $73.1M $6.36 12 Aug 2024 Through its wholly-owned subsidiary, Sanofi Foreign Participations B.V.
Icosavax, Inc. 10%+ Owner Common Stock (par value, $0.0001) 3.16M $49.4M $15.67 02 Aug 2021 Through its wholly-owned subsidiary, Aventis Inc.
MeiraGTx Holdings plc 10%+ Owner Ordinary Shares ($0.00003881 par value per share) 698K $4.44M $6.36 12 Aug 2024 Through its wholly-owned subsidiary Kadmon Corporation, LLC
Icosavax, Inc. 10%+ Owner Series A-1 Preferred Stock (par value, $0.0001) 0 02 Aug 2021 Through its wholly-owned subsidiary, Aventis Inc
Icosavax, Inc. 10%+ Owner Series B-1 Preferred Stock (par value, $0.0001) 0 02 Aug 2021 Through its wholly-owned subsidiary, Aventis Inc

Insider Reports Filed by Sanofi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MGTX MeiraGTx Holdings plc 12 Aug 2024 0 $0 3 10%+ Owner 13 Aug 2024, 06:30
TBIO Translate Bio, Inc. 14 Sep 2021 2 $2.74B 4 10%+ Owner 14 Sep 2021, 09:59
TBIO Translate Bio, Inc. 02 Aug 2021 0 $0 3 Other* 12 Aug 2021, 16:00
ICVX Icosavax, Inc. 02 Aug 2021 4 $1M 4 10%+ Owner 02 Aug 2021, 20:34
ICVX Icosavax, Inc. 28 Jul 2021 0 $0 3 10%+ Owner 28 Jul 2021, 20:32